登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C16H23N11O2S5
化学文摘社编号:
分子量:
561.75
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
biological source
synthetic
grade
pharmaceutical primary standard
agency
USP
API family
famotidine
form
powder
packaging
pkg of 25 mg
manufacturer/tradename
USP
storage condition
protect from light
color
yellow to white
solubility
water: soluble
application(s)
pharmaceutical (small molecule)
format
neat
InChI
1S/C16H23N11O2S5/c17-13(18)24-15-21-9(7-32-15)5-30-3-1-11-23-12(27-34(28,29)26-11)2-4-31-6-10-8-33-16(22-10)25-14(19)20/h7-8H,1-6H2,(H,23,26,27)(H4,17,18,21,24)(H4,19,20,22,25)
InChI key
NRRXZFHNRLQONH-UHFFFAOYSA-N
General description
Famotidine Related Compound B (Famotidine Impurity B) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
Application
Famotidine Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Famotidine
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals
Helali N, et al.
Talanta, 74(4) (2008)
Famotidine
Pharmacopeia, US
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
Potentiometric determination of famotidine in pharmaceutical formulations
Ayad MM, et al.
Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 1269221-25MG | 04061833830215 |